Category Archives: Neuroscience

Increased Long-Covid Risk for Those With Sleep Apnea – Neuroscience News

Summary: The risk of developing long COVID symptoms may be significantly increased in adults with sleep apnea, according to a new study.

This increased risk persisted even when controlling for other factors known to contribute to long COVID, such as obesity, hypertension, diabetes, and hospitalization at the time of initial COVID infection. Notably, the link between sleep apnea and long COVID was not observed in children when other risk factors were accounted for.

This research underlines the importance of early COVID treatment and symptom vigilance in sleep apnea patients.

Key Facts:

1 Adults with sleep apnea have a significantly increased risk of developing long COVID symptoms, according to a study by the National Institutes of Healths RECOVER Initiative and NYU Langone Health.

2 The increased risk for long COVID in adults with sleep apnea persisted even when accounting for factors such as obesity, hypertension, diabetes, and initial COVID hospitalization.

3 In contrast to the patterns seen in adults, the contribution of sleep apnea to the risk of long COVID was not significant in children when controlled for other risk factors.

Source: NYU Langone

Sleep apnea may significantly increase the risk for long COVID in adults, according to a study led by theNational Institutes of Healths RECOVER Initiativeand supported by NYU Langone Health as home to the efforts Clinical Science Core (CSC).

As ofApril 2023,more than 100 million Americans had been infected with the virus that causes COVID-19. As of April the U.S.Governments Household Pulse survey estimated that about 6 percent of U.S. adults are experiencingsymptoms associated with long COVID, including brain fog, fatigue, depression, and sleep problems.

Past studies have shown that patients with obstructive sleep apnea (OSA) tend to have more severe illness when initially infected with COVID-19. OSA affects about1 in 8adults but is often underdiagnosed.

To better understand links between sleep apnea and long-term COVID symptoms, the research team reviewed data across three RECOVER research networks of patients who had tested positive for COVID-19 between March 2020 and February 2022, according to their health records.

Two networks included adult patients the National Patient-Centered Clinical Research Network (PCORnet) with 330,000 patients and the National COVID Cohort Collaborative (N3C) with 1.7 million patients. The third patient cohort in the study analysis included the pediatric-focused network PEDSnet, made up of 102,000 children.

Published online on May 11 in the journalSleep,this study found that a prior diagnosis of sleep apnea in the PCORnet group came with a 12 percent increase in risk for long-term symptoms months after patients initial infections.

In the N3C patient group, in which patients had higher levels of other chronic conditions than those in PCORnet, sleep apnea came with a 75 percent increase in risk for long COVID compared to those without sleep apnea.

The observed increases in risk for long COVID in adults with sleep apnea remained significant even when the research team accounted for obesity, hypertension, diabetes, and hospitalization at the time of their initial COVID infection, all known to independently contribute to risk for long COVID.

The researchers hypothesize that the differences in the percentage increases in long COVID risk between the study groups may be further explained by variations indefinitionsof long COVID, study populations, and in analysis methods of patient records, across the large study.

In contrast to the patterns seen in adults, the contribution of sleep apnea to the risk of long COVID disappeared in children when the researchers controlled for other risk factors, including obesity.

A strength of the work is that the link between sleep apnea and long COVID persisted regardless of how the researchers in our study defined long COVID or gathered data,says senior study author Lorna Thorpe, PhD, MPH, Professor and Director of the Division of Epidemiology at NYU Langone Health.

She is also co-lead of efforts to understand long COVID using electronic health record networks for the RECOVER CSC at NYU Langone.

This study is the first collaboration of this focus and scale to find that adults with sleep apnea are at greater risk for long COVID.

RECOVERResearching COVID to Enhance Recoveryis dedicated to understanding why some people develop long-term symptoms following a COVID infection, and how to detect, treat, and prevent long COVID. As the CSC, NYU Langone Health is charged with integrating research activities of clinical sites around the country.

Theres still so much to uncover about long COVID, but this study will inform clinical care by identifying patients that should be watched more closely, says corresponding author Hannah Mandel, a senior research scientist for the electronic health record studies arm of the RECOVER CSC at NYU Langone Health.

People with sleep apnea who get infected with COVID should seek early treatment, pay attention to their symptoms, and keep up with their vaccinations to lower the risk of infection in the first place.

Interestingly, in the N3C study group, long COVID risk was higher among women with sleep apnea compared to men with sleep apnea.

Investigators identified an 89% increased likelihood for having long COVID in women, compared to a 59% increased chance for men.

The reasons for this are not clear, butwomenwith diagnosed sleep apnea in their medical records may have more severe conditions than men, in part because women with sleep apnea tend to go undiagnosed with OSA for longer.

Funding: The study was funded by RECOVER (OT2HL161847) and received additional support from the National Center for Advancing Translational Sciences (UL1TR002494).

For more information on RECOVER, visithttps://recovercovid.org.

Author: Gregory WilliamsSource: NYU LangoneContact: Gregory Williams NYU LangoneImage: The image is credited to Neuroscience News

Original Research: Open access.Risk of post-acute sequelae of SARS-CoV-2 infection associated with pre-coronavirus disease obstructive sleep apnea diagnoses: an electronic health recordbased analysis from the researching coronavirus disease to enhance recovery initiative by Lorna Thorpe et al. SLEEP

Abstract

Risk of post-acute sequelae of SARS-CoV-2 infection associated with pre-coronavirus disease obstructive sleep apnea diagnoses: an electronic health recordbased analysis from the researching coronavirus disease to enhance recovery initiative

Study Objectives

Obstructive sleep apnea (OSA) has been associated with more severe acute coronavirus disease-2019 (COVID-19) outcomes. We assessed OSA as a potential risk factor for Post-Acute Sequelae of SARS-CoV-2 (PASC).

Methods

We assessed the impact of preexisting OSA on the risk for probable PASC in adults and children using electronic health record data from multiple research networks. Three research networks within the REsearching COVID to Enhance Recovery initiative (PCORnet Adult, PCORnet Pediatric, and the National COVID Cohort Collaborative [N3C]) employed a harmonized analytic approach to examine the risk of probable PASC in COVID-19-positive patients with and without a diagnosis of OSA prior to pandemic onset. Unadjusted odds ratios (ORs) were calculated as well as ORs adjusted for age group, sex, race/ethnicity, hospitalization status, obesity, and preexisting comorbidities.

Results

Across networks, the unadjusted OR for probable PASC associated with a preexisting OSA diagnosis in adults and children ranged from 1.41 to 3.93. Adjusted analyses found an attenuated association that remained significant among adults only. Multiple sensitivity analyses with expanded inclusion criteria and covariates yielded results consistent with the primary analysis.

Conclusions

Adults with preexisting OSA were found to have significantly elevated odds of probable PASC. This finding was consistent across data sources, approaches for identifying COVID-19-positive patients, and definitions of PASC. Patients with OSA may be at elevated risk for PASC after SARS-CoV-2 infection and should be monitored for post-acute sequelae.

More:
Increased Long-Covid Risk for Those With Sleep Apnea - Neuroscience News

Depression Symptoms in Older People on the Decline – Neuroscience News

Summary: A recent study reveals that todays 75- and 80-year-olds experience fewer depressive symptoms and greater life satisfaction than their counterparts from the 1990s. The improvement in mental well-being is attributed to better-perceived health and higher education among the aging population. The research further supports the notion that older individuals today have better physical and cognitive functioning than those born earlier.

Key Facts:

Source: University of Jyvskyl

Depressive symptoms have decreased among older people and they are more satisfied with their lives so far than people at the same age three decades ago.

This was observed in a study conducted at the Gerontology Research Center at the Faculty of Sport and Health Sciences, University of Jyvskyl (Finland).

The study examined differences in depressive symptoms and life satisfaction between current 75- and 80-year-olds and same-aged people who lived in the 1990s.

The results showed that 75- and 80-year-old men and women today experience fewer depressive symptoms than those who were 75 and 80 years old in the 1990s. The differences were partly explained by the better-perceived health and higher education of those born later.

In our previous comparisons, we found that older people today have significantly better physical and cognitive functioning at the same age compared to those born earlier, says ProfessorTaina Rantanenfrom the Faculty of Sport and Health Sciences.

These new results complement these positive findings in terms of mental well-being.

Today, 75- and 80-year-olds are more satisfied with their lives to date. However, 80-year-old men who lived in the 1990s were even more satisfied with their current lives than 80-year-old men today.

These men born in 1910 had lived through difficult times, which may explain their satisfaction with their current lives in the 1990s when many things were better than before, says postdoctoral researcherTiia Keklinen.

Individuals adapt to their situation and living conditions. Both in the 1990s and today, the majority of older adults reported being satisfied with their current lives.

The study was conducted at the Faculty of Sport and Health Sciences and Gerontology Research Center at University of Jyvskyl, Finland.

The first cohort consisted of 617 individuals born in 1910 and 1914 who participated in the Evergreen study in 19891990. The second cohort consisted of 794 individuals born in 19381939 and 19421943 who participated in the AGNES study in 20172018. In both cohorts, the participants were assessed at the age of 75 or 80 years.

Funding: The study was funded by the Academy of Finland and the European Research Council.

Author: Tiia KeklinenSource: University of JyvskylContact: Tiia Keklinen University of JyvskylImage: The image is credited to Neuroscience News

Original Research: Open access.Cohort Differences in Depressive Symptoms and Life Satisfaction in 75- and 80-Year-Olds: A Comparison of Two Cohorts 28 Years Apart by Keklinen, T et al. Journal of Aging and Health

Abstract

Cohort Differences in Depressive Symptoms and Life Satisfaction in 75- and 80-Year-Olds: A Comparison of Two Cohorts 28 Years Apart

To examine birth cohort differences in depressive symptoms and life satisfaction in older men and women and the mechanisms underpinning the possible cohort differences.

Two independent cohorts of Finnish men and women aged 75 and 80 were assessed in 19891990 (n= 617) and 20172018 (n= 794). They reported their depressive symptoms (CES-D), current life satisfaction, and evaluation of life until now.

The later-born cohort reported fewer depressive symptoms (8.6 7.1 vs. 13.9 8.3) and the differences were similar for the subdomains of depressive symptoms. The later-born cohort was more often mostly satisfied with life until now (90 vs. 70%) but not with the current life than the earlier-born cohort. Better self-rated health and education of the later-born cohort partly explain the cohort differences.

Older people in Finland report fewer depressive symptoms and they are more satisfied with their past life compared to their counterparts assessed 28years ago.

Go here to read the rest:
Depression Symptoms in Older People on the Decline - Neuroscience News

Menthol Inhalation May Boost Cognitive Ability in Alzheimer’s – Neuroscience News

Summary: Menthol inhalation can improve cognitive abilities in animal models of Alzheimers disease, researchers report.

Short, repeated exposure to menthol can modulate the immune system and prevent cognitive decline commonly seen in Alzheimers.

Researchers found that the smell of menthol reduced the level of interleukin-1-beta (IL-1b), a protein crucial to the inflammatory response. By inhibiting this protein with a specific drug, cognitive abilities were also improved in the mice models.

This research suggests the possibility of therapies based on stimulating the olfactory system to counteract Alzheimers and other central nervous system diseases.

Key Facts:

Source: Universidad de Navarra

Researchers fromCima University of Navarra(Spain) have shown in animal models ofAlzheimers diseasethat inhaling menthol improves cognitive ability.

This study discovered that repeated short exposures to this substance can modulate the immune system and prevent the cognitive deterioration typical of this neurodegenerative disease.

When analyzing its mechanism of action, they observed that when smelling this aroma, the level ofinterleukin-1-beta (IL-1b), a critical protein mediating the inflammatory response, was reduced.

Furthermore, by inhibiting this protein with a drug approved for the treatment of some autoimmune diseases, they were also able to improve cognitive ability in these diseased mice.

This research highlights the potential of odors and immune modulators as therapeutic agents. Furthermore, it opens the door to developing therapies based on stimulating and training the olfactory system to prevent or alleviate the effects of Alzheimers and other diseases of the central nervous system.

Frontiers in Immunologypublished the results of this study in its latest issue.

The functional balance of the brain depends on complex interactions between various types of nerve cells, immune cells, and neural stem cells. In this complex web of interactions, several studies have addressed the immunomodulatory and neurological effects of odorants.

Other previous works have also shown a correlation between the loss of the sense of smell and the appearance of the first symptoms of Alzheimers disease.

We have focused on the olfactory systems role in the immune and central nervous systems, and we have confirmed that menthol is an immunostimulatory odor in animal models.

But, surprisingly, we observed that short exposures to this substance for six months prevented cognitive decline in the mice with Alzheimers and, what is most interesting, also improved the cognitive ability of healthy young mice, says DrJuan Jos Lasarte.

Another result noted by the researchers is that blocking the activity of T regulatory cells, one type of immune cells with immunosuppressive activity, also improved the cognitive ability of mice with Alzheimers disease and also caused a clear benefit in the cognitive ability of healthy young mice, explains Dr.Ana Garca-Osta.

Both menthol exposure and Treg cell blockade caused a decrease in IL-1b, a protein that could be behind the cognitive decline observed in these models. In addition, the specific blockade of this protein with a drug used in treating some autoimmune diseases also improved the cognitive capacity of healthy mice and mice with Alzheimers.

This study is an important step toward understanding the connection between the immune system, the central nervous system and smell, as the results suggest that odors and immune modulators may play an important role in the prevention and treatment of Alzheimers. and other diseases related to the central nervous system, points out Dr.Noelia Casares.

Funding: The Government of Navarra and the Ministry of Economy and Competitiveness financed this work. It is part of the Instituto de Investigacin Santiaria de Navarra (IdiSNA). It is also part of the INNOLFACT project, a multicenter consortium coordinated by Dr Enrique Santamara, a Navarrabiomed researcher.

This consortium aims to study the olfactory function in aging and develop new immunomodulatory therapies to slow down the development of neurodegenerative diseases.

Author: Miriam SalcedoSource: Universidad de NavarraContact: Miriam Salcedo Universidad de NavarraImage: The image is credited to Neuroscience News

Original Research: Open access.Improvement of cognitive function in wild-type and Alzheimers disease mouse models by the immunomodulatory properties of menthol inhalation or by depletion of T regulatory cells by Casares Noelia et al. Frontiers in Immunology

Abstract

Improvement of cognitive function in wild-type and Alzheimers disease mouse models by the immunomodulatory properties of menthol inhalation or by depletion of T regulatory cells

A complex network of interactions exists between the olfactory, immune and central nervous systems. In this work we intend to investigate this connection through the use of an immunostimulatory odorant like menthol, analyzing its impact on the immune system and the cognitive capacity in healthy and Alzheimers Disease Mouse Models.

We first found that repeated short exposures to menthol odor enhanced the immune response against ovalbumin immunization. Menthol inhalation also improved the cognitive capacity of immunocompetent mice but not in immunodeficient NSG mice, which exhibited very poor fear-conditioning.

This improvement was associated with a downregulation of IL-1 and IL-6 mRNA in the brains prefrontal cortex, and it was impaired by anosmia induction with methimazole.

Exposure to menthol for 6 months (1 week per month) prevented the cognitive impairment observed in the APP/PS1 mouse model of Alzheimer. Besides, this improvement was also observed by the depletion or inhibition of T regulatory cells.

Treg depletion also improved the cognitive capacity of the APPNL-G-F/NL-G-FAlzheimers mouse model. In all cases, the improvement in learning capacity was associated with a downregulation of IL-1 mRNA. Blockade of the IL-1 receptor with anakinra resulted in a significant increase in cognitive capacity in healthy mice as well as in the APP/PS1 model of Alzheimers disease.

These data suggest an association between the immunomodulatory capacity of smells and their impact on the cognitive functions of the animals, highlighting the potential of odors and immune modulators as therapeutic agents for CNS-related diseases.

Link:
Menthol Inhalation May Boost Cognitive Ability in Alzheimer's - Neuroscience News

High-Resolution Image of the Human Retina Reveals Stunning Details – Neuroscience News

Summary: Researchers developed a new imaging technique to visualize several dozen proteins in a thin tissue section at high resolution using fluorescence microscopy.

The technique enabled researchers to map the development of human retinal organoids at high temporal and spatial resolution, providing insights into how healthy tissue forms and developing a time series that describes the entire 39-week development of retinal organoids.

The researchers aim to apply this approach to other tissue types, such as the human brain and various tumor tissues, creating an atlas that provides information on the development of human organoids and tissues.

Key Facts:

Source: ETH Zurich

What cell types are found in which human tissue, and where? Which genes are active in the individual cells, and which proteins are found there?

Answers to these questions and more are to be provided by a specialized atlas in particular how the different tissues form during embryonic development and what causes diseases.

In creating this atlas, researchers aim to map not only tissue directly isolated from humans, but also structures called organoids. These are three-dimensional clumps of tissue that are cultivated in the laboratory and develop in a way similar to human organs, but on a small scale.

The advantage of organoids is that we can intervene in their development and test active substances on them, which allows us to learn more about healthy tissue as well as diseases, explains Barbara Treutlein, Professor of Quantitative Developmental Biology at the Department of Biosystems Science and Engineering at ETH Zurich in Basel.

To help produce such an atlas, Treutlein, together with researchers from the Universities of Zurich and Basel, has now developed an approach to gather and compile a great deal of information about organoids and their development. The research team applied this approach to the organoids of the human retina, which they derived from stem cells.

Many proteins visible simultaneously

At the heart of the methods the scientists used for their approach was the 4i technology: iterative indirect immunofluorescence imaging. This new imaging technique can visualize several dozen proteins in a thin tissue section at high resolution using fluorescence microscopy.

The 4i technology was developed a few years ago by Lucas Pelkmans, a professor at the University of Zurich and coauthor of the study that has just been published in the scientific journalNature Biotechnology.

It is in this study that the researchers applied this method to organoids for the first time.

Typically, researchers use fluorescence microscopy to highlight three proteins in a tissue, each with a different fluorescent dye.

For technical reasons, it is not possible to stain more than five proteins at a time. In 4i technology, three dyes are used, but these are washed from the tissue sample after measurements have been taken, and three new proteins are stained. This step was performed 18 times, by a robot, and the process took a total of 18 days.

Lastly, a computer merges the individual images into a single microscopy image on which 53 different proteins are visible. They provide information on the function of the individual cell types that make up the retina; for example, rods, cones, and ganglion cells.

The researchers have supplemented this visual information of retinal proteins with information on which genes are read in the individual cells.

High spatial and temporal resolution

The scientists performed all these analyses on organoids that were of different ages and thus at different stages of development. In this way, they were able to create a time series of images and genetic information that describes the entire 39-week development of retinal organoids.

We can use this time series to show how the organoid tissue slowly builds up, where which cell types proliferate and when, and where the synapses are located. The processes are comparable to those of retinal formation during embryonic development, says Gray Camp, a professor at the University of Basel and a senior author of this study.

The researchers published their image information and more findings on retinal development on a publicly accessible website:EyeSee4is.

Further tissue types planned

So far, the scientists have been studying how a healthy retina develops, but in the future, they hope to deliberately disrupt development in retinal organoids with drugs or genetic modifications.

This will give us new insights into diseases such as retinitis pigmentosa, a hereditary condition that causes the retinas light-sensitive receptors to gradually degenerate and ultimately leads to blindness, Camp says.

The researchers want to find out when this process begins and how it can be stopped.

Treutlein and her colleagues are also working on applying the new detailed mapping approach to other tissue types, such as different sections of the human brain and to various tumour tissues. Step by step, this will create an atlas that provides information on the development of human organoids and tissues.

Author: Press OfficeSource: ETH ZurichContact: Press Office ETH ZurichImage: The image is credited to Wahle et al. Nature Biotechnology 2023

Original Research: Open access.Multimodal spatiotemporal phenotyping of human retinal organoid development by Barbara Treutlein et al. Nature Biotechnology

Abstract

Multimodal spatiotemporal phenotyping of human retinal organoid development

Organoids generated from human pluripotent stem cells provide experimental systems to study development and disease, but quantitative measurements across different spatial scales and molecular modalities are lacking.

In this study, we generated multiplexed protein maps over a retinal organoid time course and primary adult human retinal tissue.

We developed a toolkit to visualize progenitor and neuron location, the spatial arrangements of extracellular and subcellular components and global patterning in each organoid and primary tissue. In addition, we generated a single-cell transcriptome and chromatin accessibility timecourse dataset and inferred a gene regulatory network underlying organoid development.

We integrated genomic data with spatially segmented nuclei into a multimodal atlas to explore organoid patterning and retinal ganglion cell (RGC) spatial neighborhoods, highlighting pathways involved in RGC cell death and showing that mosaic genetic perturbations in retinal organoids provide insight into cell fate regulation.

Read more here:
High-Resolution Image of the Human Retina Reveals Stunning Details - Neuroscience News

Announcing the Hackensack Meridian Health Neuroscience Institute … – Hackensack Meridian Health

Hackensack Meridian Healths three nationally-recognized neuroscience institutes at Hackensack University Medical Center, Jersey Shore University Medical Center and JFK University Medical Center are now united as Hackensack Meridian Neuroscience Institute the largest, most comprehensive Neuroscience Institute in the state. By coming together as one institute with a shared vision and mission, the three locations have strengthened their ability to provide integrated access to care and research for patients throughout New Jersey.

Under the Hackensack Meridian Neuroscience Institute umbrella, neurology and neurosurgery team members are able to leverage the network resources to provide their patients with enhanced access to evidence-based care protocols, clinical trials, technology, and subspecialty expertise closer to home, and without the need to refer patients outside HMH.

One in three people will develop a neurological disorder at some point. Neurological disorders are the leading cause of disability and among the leading causes of death in the United States. That is why where and who a patient seeks treatment for conditions like brain and spine tumors, Parkinson's disease and other movement disorders, stroke, epilepsy, Alzheimers disease, and dementia and neuromuscular diseases like multiple sclerosis, is important.

The Hackensack Meridian Neuroscience Institute offers the highest standard of care for patients with neurological illnesses, allowing us to bring together neurologists, neurosurgeons and other neurology specialists including neuropsychologists, case managers, neurointensivists, researchers and neuro-oncologists so that every facet of a neurological illness is attended to, said Timothy Hogan, FACHE, executive vice president of Hackensack Meridian Health Care Transformation Services. The Institute allows for even greater connectivity and collaboration, to allow patients access to the highest quality care in all the regions we serve throughout New Jersey.

Hackensack Meridian Health has the largest neurology and neurosurgery program in New Jersey and is home to the states only nationally ranked neurology and neurosurgery program at Hackensack University Medical Center. The Neuroscience Institutes accolades include the following:

Patients will also have access to nationally ranked neurological rehabilitation services at the JFK Johnson Rehabilitation Institute, ranked by US News & World Report as one of the top rehabilitation hospitals in the country.

The Hackensack Meridian Neuroscience Institute allows patients access to state-of-the-art care and advanced therapies through new research and clinical trials, including trials in neurological conditions like amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), Alzheimers disease, Charcot-Marie-Tooth disease (CMT), spinal cord injury, brain tumors and migraines.

Collaboration throughout Hackensack Meridian Healths vast healthcare network allows other underlying medical causes for neurological disorders to be addressed. For example, Hackensack University Medical Center has established a Heart and Brain Clinic to evaluate and treat people with patent foramen ovale (PFO) a small hole in the heart who have had a stroke not due to other causes and who are at risk of a second stroke. The clinic is a collaboration between the medical centers renowned cardiology and neurology experts in one multidisciplinary program and is the first-of-its-kind in New Jersey. At the Neuroscience Institutes Center for Memory Loss and Brain Health, patients have access to cognitive neurologists, geriatricians, health & neuro-psychologists and social workers for comprehensive care to all parts of memory loss diseases.

Hackensack Meridian Neuroscience Institute Offers Advanced Technology

The Neuroscience Institute offers premiere technology for treatment of neurological disease and disorders that cannot be found at most other institutions. The Neuroscience Institute is now equipped with Quicktome brain mapping technology, an innovation in imaging to map brain networks and electrical connections to preserve them during surgery, allowing surgeons to plot out a surgery that would limit the amount of brain tissue impacted. The Hackensack Meridian Neuroscience Institute sites are the first locations in New Jersey and only a few in the Northeast with this technology.

The Neuroscience Institute at Hackensack University Medical Center is home to New Jerseys first intraoperative MRI system, used during neurosurgical and neuro-interventional procedures to help neurosurgeons accurately remove tumors and treat conditions such as Parkinsons disease, epilepsy and more. Similar technology, including Clear Point brings MRI technology into the operation room, allowing patients to undergo deep brain stimulation (DBS) while asleep rather than awake.

The Hackensack Meridian Neuroscience Institute at Hackensack University Medical Center and later this year, Jersey Shore University Medical Center are the only locations in New Jersey to offer High Intensity Focused Ultrasound (HiFU). This unique non-invasive procedure effectively treats Parkinsons tremors and essential tremors in cases where managing with medication hasnt been effective, allowing patients to return to their normal activities without debilitating tremors.

For the treatment of brain cancer and other conditions of the head and neck, the Neuroscience Institute at Jersey Shore University Medical Center will offer Zap-X beginning this summer, a non-invasive precision treatment that delivers high-dose radiation to brain tumors, facial pain and arteriovenous malformations or twisted blood vessels that can cause clots leading to stroke, without destroying healthy brain cells. The Neuroscience Institute will be the sixth in the nation to have Zap-X, the only one in the Northeast, and globally the first to pair it with Synaptive MRI, shortening the time from diagnosis to treatment. The Neuroscience Institute also skillfully uses gamma knife and fluorescence-targeted radiation in the treatment of brain tumors, tremors and other neurological issues.

If brain or spine surgery is required, the Neuroscience Institute at JFK University Medical Center is one of a handful of hospitals nationally and the only one in New Jersey offering 3D imaging technology and intraoperative augmented reality imaging during surgery known as Surgical Theater. Neurosurgeons slip on a virtual reality headset and see exceptionally detailed images to determine the best strategy to target pathologies while preserving normal tissue. Doctors also use this technology to practice a surgery before they perform it and to demonstrate to patients what needs to be done.

Other technology available at the Hackensack Meridian Neuroscience Institute include Laser Interstitial Thermal Therapy (LiTT Technology), a minimally invasive surgical option for people with drug-resistant epilepsy and select brain tumors. DaTSCAN Camera, one of the most advanced diagnostic imaging technologies available, visualizes dopamine transporter levels in the brain. This is an effective tool in diagnosing Parkinsons disease and other movement disorders.

Neuroscience Institute surgeons are skilled at using DBS to surgically implant a pacemaker-type device into the brain to control tremors. For sleep disorders, the Hackensack Meridian Neuroscience Institute offers two surgical options for obstructive sleep apnea that cannot be controlled with a CPAP machine.

Hackensack Meridian Neuroscience Institute Has World-Class Physicians

The Neuroscience Institutes advanced technology is even more powerful in the hands of its world-class physicians. From neurology, neuro-surgery, neuro-oncology, movement disorders, stroke, memory disorders, sleep, and headaches, the Hackensack Meridian Neuroscience Institute offers expert physicians in all areas. The Institutes doctors are leaders and innovators in neurological treatments and surgeries. Bringing them all together in one institute allows more collaboration to combat a patients illness.

No matter the neurological issue, the Hackensack Meridian Neuroscience Institute has a specialist ready to treat it with knowledge, compassion, and state-of-the-art tools in the hands of our renowned neurologists, neurosurgeons, and neuro-oncologists, said Maria Coello, vice president of Care Transformation Services including Neurosciences, Hackensack Meridian Health.

Hackensack Meridian Neuroscience Institute Participates in Groundbreaking Research

The Hackensack Meridian Neuroscience Institute continues to innovate new treatments for neurological ailments, as technology and science evolve, participating in clinical trials and groundbreaking research. Neuroscience Institute patients are able to access cutting-edge technology and treatment breakthroughs for their neurological disorders.

Scientists at the Hackensack Meridian Neuroscience Institute are researching and participating in clinical trials on topics including treatments for traumatic brain injury, Alzheimers disease, multiple sclerosis, and stroke.

Teaching Future Physicians at Hackensack Meridian School of Medicine

The physicians at the Hackensack Meridian Neuroscience Institute are also professors at the Hackensack Meridian School of Medicine, the first private medical school opened in New Jersey in more than 50 years, which is training the next generation of neurologists and neurosurgeons on the innovative treatments and advancements being made. The School of Medicines progressive curriculum trains future doctors to not only treat a patients medical condition, but the underlying social determinants of health affecting them. The unique school trains diverse doctors who look like the country and the patients they serve. Nearly half of the class admitted in 2020 is female, and students speak 33 languages. Half of the class identifies as persons of color (other than white), and a quarter are from groups categorized as under-represented in medicine. Studies show patients are more likely to respond to a doctor from their cultural or ethnic background. More than half of the School of Medicine students go on to residencies at Hackensack Meridian hospitals, including within the Neuroscience Institute.

The new Hackensack Meridian Neuroscience Institute advertising campaign launches the week of April 3. Click here to watch our new television commercial.

Read more:
Announcing the Hackensack Meridian Health Neuroscience Institute ... - Hackensack Meridian Health

CZIs Grant for Diversity in Neuroscience is a Positive Development … – Inside Philanthropy

With its February announcement of a two-year, $1 million grant to a new Baltimore initiative focused on racial disparities in the field of neuroscience, the Chan-Zuckerberg Initiative didnt just take another step toward its goal of funding research leading to the cure or treatment of all human disease by the end of this century. The grant is also a step toward ensuring that fewer people will be left out of both the process and the benefits of that research.

CZIs grant will help fund the development of the African Ancestry Neuroscience Research Initiative (AANRI), a partnership between Baltimores Lieber Institute for Brain Development, historically Black Morgan State University, and community leaders helmed by the Rev. Dr. Alvin C. Hathaway, the retired pastor of West Baltimores Union Baptist Church. First announced in 2019, AANRIs aims include alleviating the Black communitys distrust of the medical and research establishment, eventually improving health outcomes by vastly increasing the racial diversity of donated brains available to neuroscientists studying the causes and treatments of everything from psychiatric disorders to Alzheimers Disease, and diversifying the field of neuroscience itself. AANRI has also attracted support from the Abell Foundation, Brown Capital Management, and the state of Maryland.

When it comes to the ways that the countrys health care system has betrayed and failed Black Americans, the infamous Tuskegee syphilis experiments of the 20th century are just one example of medicines many tresspasses. Other examples of medical neglect and outright abuse of Black patients includes forced sterilization, frequent failures to treat their pain or take it seriously, and the disparate toll of the COVID-19 pandemic.

There are also glaring disparities among practitioners. Only 4% of American physicians are Black, and its too early to tell whether the notable increase in Black medical school applicants in 2021 will translate to more representation in the profession. Given that history and todays reality, it shouldnt come as a surprise that underrepresented minority groups, including Black Americans, comprise less than 5% of the research cohorts in neuroscience research studies.

The lack of Black representation in neuroscience research subjects is a real problem in a country where Black Americans are twice as likely to develop Alzheimers, 20% more likely to develop serious mental health problems, and suicide rates for Black children under 13 are twice as high as the rates of children of European ancestry, according to AANRIs website.

Increasing the diversity of donated brains to study isnt just about being representative for the sake of being representative and fair and proportionate, said CZI Science Program Officer Katja Brose, who holds a Ph.D. in biochemistry. Instead, she said, its about bringing a deep and thorough level of science to bear on questions like the contributions of differences in genetics, or how much of an impact differing environments and life experiences, including experiences of racism, have on determining who may develop a brain disorder.

To put it another way, we dont even know what we dont know, said Patricia Flores, a senior communications associate at CZI who works closely with several of the funders scientists. We just know that were missing a large swath of the pot. The majority of the globe is being missed in the science that we understand today.

Is science funding diversifying?

CZIs grant to develop AANRI is only one of several moves in the past few years aiming to promote more diversity in the sciences. In 2021, for example, the MacArthur Foundation committed $2 million to the Native Biodata Consortium, the worlds first Indigenous-led bio-repository, which, like AANRI, is also working to both diversify the field of medical research and help insure that the subjects of that research benefit from its results. Last year, the Howard Hughes Medical Institute launched a $2 billion initiative to diversify academic science more broadly.

CZI is also no stranger to moving money to promote greater diversity in the sciences. A quick look at the funders grants database reveals money being moved to scientific organizations focused on underrepresented groups, efforts like AANRI to diversify sample studies, and, in a 2021 grant to the Americas Health Foundation, efforts to advance a more equitable rare disease advocacy and research ecosystem in the Caribbean and Latin America.

Beyond the anecdotal evidence, its hard to say whether were seeing an overall uptick in funding in this area, but theres definitely a lot of room for more such giving considering the far reach of federal and philanthropic science funding. The National Institutes of Health alone reports that it dedicates most of its $45 billion budget to medical research; last year, one study identified about $30 billion in annual philanthropic funding for scientific work.

One way well truly know whether scientific funding, including money for medical research and to train new scientists and doctors, has truly diversified will be by watching for practical results. Are health disparities improving or disappearing? How common is it for a patient to be seen by a doctor or other health specialist whos Black or another person of color? In the meantime, well do our best to shout out funders efforts to promote diversity in the sciences and call out funders who dont seem to have gotten the memo.

Here is the original post:
CZIs Grant for Diversity in Neuroscience is a Positive Development ... - Inside Philanthropy

SME Topeka welcomes speaker connecting neuroscience to the real world – WIBW

Abortion opponents pushed a bill through the Kansas Legislature early Friday to require providers to tell patients that a medication abortion can be reversed once its started a measure that could face a state court challenge if its supporters can overcome the governors expected veto.

Go here to read the rest:
SME Topeka welcomes speaker connecting neuroscience to the real world - WIBW

Behavioral Neuroscience Program awards pair of summer research … – Western Washington University

The Behavioral Neuroscience Program is pleased to announce the 2023 recipients of the BNS Program Undergraduate Summer Research Award and the Dr. David Goldman and Dr. Linda Blackwell Undergraduate Summer Research Award. Both research awards aim to increase opportunities in Behavioral Neuroscience research for individuals who are typically underrepresented in the field. The awards will be given annually to a Behavioral Neuroscience undergraduate with demonstrated interest in behavioral neuroscience research, enthusiasm for a graduate degree or health professional program, and has financial need.

This years BNS Program Summer Undergraduate Research Award recipient is Lauren Gilman (she/her), who works in the lab of Josh Kaplan, an associate professor in the Department of Psychology. Gilman wants to become an osteopathic psychiatrist after graduation and this summer will research cannabis effects on autism spectrum disorder.

Im thrilled that Lauren will have the opportunity to explore her research interests this summer, and Im looking forward to supporting her scientific growth as she learns new molecular approaches that will be applied to her research into cannabis effects in autism spectrum disorder," said Kaplan. "Lauren will now be able to apply her holistic approach to medicine and research by studying the effect of cannabis on the gut-brain axis, neuroinflammation, and behavior using molecular and mass spectrometry approaches. These are hot areas of research and Im excited for Lauren to lead our lab in this new direction."

Gilman was grateful for the research award and excited to get to work this summer.

"I am grateful for this award and honored to be a presence for other queer women in STEM. My time at Western has given me immense opportunities for growth and leadership. To name a few, I participated in the psychiatry internship, as the NeRDS publicity officer, as the waterski team travel coordinator, and as a volunteer in Dr. Kaplan's cannabis lab," Gilman said. "I hope my research on the microbiome and inflammation in autism spectrum disorder increases our understanding of CBD and paves the way for other safe, novel treatments."

"In the future, I hope to work as an osteopathic psychiatrist, providing a holistic approach to healing. Admittedly, many psychiatric disorders have a biological basis and require pharmacological intervention to improve symptoms; however, I plan to approach patients as people first, not as an array of dysfunctional circuits and chemicals. Environment, social connections, and underlying disease impact the minds state just as much as neurotransmitters and deserve equal attention," she said.

Here is the original post:
Behavioral Neuroscience Program awards pair of summer research ... - Western Washington University

Data and Tools Integration in the Canadian Open Neuroscience … – Nature.com

The platform design relies on open formats, APIs, and standards to allow for extensibility and promote interoperability. The key design ideas are based on the following constraints and considerations:

The platform should integrate data resources from different infrastructures,

Data and tools should be integrated without undue duplication,

Integration of data and tools in the platform by community members should be feasible,

Datasets and processing tools should implement the FAIR principles,

Data governance should remain with the original data stewards or providers,

The platform should rely on open formats and standards to foster reuse and integration with other projects, and

The portal should provide intuitive navigation and provide users with documentation and help resources.

The CONP consists of several key components (Fig.1, see also Table4):

A data infrastructure layer, incorporating disparate independent data repositories (e.g., Zenodo, http://www.zenodo.org, LORIS7, or the Open-Science Framework OSF5);

A (meta)data integration layer, leveraging DataLad13, GitHub14, Boutiques tool descriptors12, enabling uniform data search queries based on the Data Tags Suite (DATS) model15;

An analysis layer that allows for simple download of tools and easy use of High-Performance Computing (HPC) environments; and

An interface layer, which controls the interaction between these components and will be outlined further in the Results section.

Architecture of the Canadian Open Neuroscience Platform. The platform is comprised of multiple tiers including: (i) Independent data infrastructure; (ii) Metadata integration across tools and datasets via standard models (Biocaddie DATS, Boutiques descriptors); (iii) Data analysis on High-Performance Computing and; (iv) Web and command-line interfaces.

The CONP takes advantage of distributed data repositories, each with their own infrastructures, access control requirements, APIs, and licensing. This importantly gives flexibility to manage collections using specific context-appropriate tools, rather than prescribing an incomplete one-size-fits-all solution. The CONP presently supports accessing and integrating data from several flexible domain-agnostic datastores (OSF, Zenodo, FRDR-DFDR, https://www.frdr-dfdr.ca/), specific brain imaging repositories (LORIS, XNAT, Brain-CODE), and the commonly used HTTP and FTP web protocols. This set of supported infrastructures is intentionally extensible to any other repository which allows access via programmatic web-compatible interfaces (e.g. a RESTful API).

To integrate datasets across infrastructures, the CONP uses DataLad as a backend and GitHub to host the metadata. Crawlers automate both the discovery of tools (on Zenodo, http://www.zenodo.org) and datasets (on Zenodo and OSF) and the DataLad and GitHub integration workflows. CircleCI16 continuously tests if datasets are available and if data are accessible by testing the download of a few files from the datasets.

The CONP adopts a decentralized architecture, to accommodate the various governance, ethical, and performance models required by data owners. For instance, some datasets may not easily be stored outside of the jurisdiction where they were acquired, while some institutions require local control of data storage, with some projects preferring to remain in control of access rules. This is all possible in CONP, as data can remain hosted anywhere on the internet.

Integration between datasets is provided by DataLad, a software library for managing Git repositories that references data. In DataLad, datasets are described in a Git repository containing metadata, file URLs and hashes of data blobs managed by git-annex. Importantly, a DataLad dataset does not generally contain the data themselves, which remain stored remotely. DataLad datasets can also be nested to represent dataset aggregation.

The CONP dataset consists of a main DataLad dataset and its metadata stored on GitHub (github.com/CONP-PCNO/conp-dataset) and referenced in the main DataLad index (http://datasets.datalad.org). The use of GitHub enables a variety of features useful for open-source software development; including issue tracking, code reviews, pull requests, branch protection, and integration with various applications. Datasets are integrated as Git submodules of the main dataset, and may be hosted on GitHub or on any other platform including GitLab or even a simple web server. This has the added benefit of being able to point to a specific commit, allowing continued evolution of the remote subdataset while the CONP portal keeps a reference to the stable version of the root dataset. Any DataLad dataset can be integrated into CONP provided that it contains a README file and a Data Tags Suite (DATS17) model file describing it. In addition, a configuration script can be added to the root of the dataset, to perform any required initialization.

The data themselves can be stored in any server implementing a protocol supported by git-annex, including HTTP, FTP, and many more. We used this flexibility to integrate data coming from three main types of sources. First, brain data archives such as the LORIS7, XNAT18, and Brain-CODE19 platforms provide a complete neuroscience data management solution for data ingestion, quality control, visualization, access control, and querying. They are commonly used to support large-scale multi-site longitudinal studies with hundreds of participants. Second, multi-disciplinary research data archives such as Zenodo in Europe, the Open Science Framework in the USA5, and the Federated Research Data Repository (FRDR)20 in Canada, provide simple ways to share research data publicly through the web and to guarantee long-term archival, findability, and immutability of data objects through Digital Object Identifiers (DOIs). They are typically used for local studies or companion data to a publication. Third, simple internet hosts accessible through the HTTP or FTP protocol allow for flexible integration of any other data already available online. CONP also provides local data-hosting for users who do not have the resources to make use of these other options.

Through git-annex, DataLad also supports authentication protocols, a critical feature for the ethical sharing of neuroscience data with restricted access. We extended this capability to support authentication to the LORIS, Zenodo, and OSF platforms. LORIS uses a common username/password authentication, which could be added to DataLad without particular challenges. Zenodo, however, implements private data sharing through secret tokens added to the file URLs. Since the file URLs are part of the DataLad repository and are therefore publicly shared, we implemented a custom mechanism to add and remove tokens from URLs on demand.

To leverage the capabilities of existing research data archives (currently Zenodo and OSF, and in the future FRDR), we developed a crawling framework to manage the life cycle of DataLad datasets on GitHub. As a result, users can upload datasets to the CONP through these web platforms, without having to install and learn DataLad, or to become familiar with our GitHub workflow. The CONP data crawler performs the following actions, implemented as a base class containing most of the GitHub and DataLad logic, and as a set of derived classes containing the API calls specific to each crawled platform:

Search for CONP-tagged datasets in web platforms;

When a new dataset is found, create a new DataLad dataset;

When a dataset modification is detected, update the corresponding DataLad dataset;

Push modifications to CONP forked GitHub repository;

Create a pull request for each modified dataset, for the CONP maintainers to review and approve.

In addition, if no DATS model is found in the datasets, one is created automatically from the fields available in the web platforms, with minimal information such as title, license and creators.

The CONP includes a dataset testing suite to mitigate the reliability challenges of decentralized systems. We implemented the testing suite in the CircleCI platform, due to its support for multithreaded testing, FTP connections, and interactive SSH sessions in testing environments. Hosting CONP DataLad datasets on GitHub allows for transparent integration with CircleCI. Similar to a software repository, dataset tests are triggered with every GitHub pull request, and their successful execution is required for the pull request to be approved by the maintainers. To reduce execution time, the testing framework only runs the tests for the datasets influenced by the pull request.

Datasets may become unavailable for a variety of transient reasons, including network interruptions, operational downtimes of the hosting platforms, or configuration errors. To detect these issues, we configured CircleCI to periodically test all the datasets available through the CONP every four hours, providing continuous monitoring. Results of this periodical testing are stored in CircleCI artifacts and are automatically displayed as status badges in the CONP portal. To increase robustness against transient errors, we used Pytests flaky module to re-run tests three times upon failure, with a 5-second delay.

The test suite tests the following properties for every dataset:

Presence of a README file at the root of the dataset,

Presence of a DATS model complying with our extended schema,

Successful installation of the dataset with DataLad,

Integrity of the git-annex repository, and

Successful download of the four smallest files from a sample to reduce runtime.

For datasets that require authentication, we include credentials through CircleCI environment variables. To reduce the associated security risks, we configured the testing framework to skip the testing of authenticated datasets in pull requests. From these environment variables, the testing framework generates a DataLad authentication provider (LORIS, Brain-CODE), or configures the dataset to use access credentials (Zenodo). The testing suite is executed in a Docker container also available for download to replicate the testing environment.

As the CONP portal brings together two types of research objects, software tools and datasets, we have reused two metadata standards developed to document these objects. The Boutiques standard12 describes a tools execution, inputs and outputs. We chose the Data Tags Suite (DATS) model17 developed by the BioCaddie consortium (Big Data to Knowledge NIH funds) to build the Datamed (https://datamed.org/) platform, for dataset description. Datamed was designed to be an equivalent of PubMed for datasets21, and DATS follows the architecture of the Journal Article Tag Suite JATS. This choice was driven by the flexible nature of DATS and its associated material (e.g., validator, documentation). DATS also has the capacity to represent sub-datasets, a feature that can be used in association with the DataLad sub-datasets mechanism (implemented with git submodules).

These two standards are used to extract information about the research objects to be displayed in the portal, as well as provide the necessary JSON-LD information for making the datasets discoverable by Google Dataset Search. The DATS model also allows for an RDF representation of the information, which enables integration of the CONP metadata as a knowledge graph in BlueBrain Nexus22. The portal includes an advanced search interface mapped to a BlueBrain Nexus SPARQL endpoint where the DATS model files are regularly exported.

The DATS model contains a number of required fields: the name and description of the dataset, the name and affiliation(s) of the individual(s) who generated the data, the license under which a dataset is released, keywords, and data types and formats. It may also include details regarding related publications, funding bodies, and cross-referencing derived datasets. We have also applied the extensibility of the DATS model to add specific fields such as a structured record of the datasets source, allowing searches by institution, city, or country of origin17.

The CONP portal goes beyond the findability of tools, directly integrating tools into workflows and enabling their execution on HPC systems.

Analysis tools are uniformly described in Boutiques, an open specification and software library for sharing tools according to the FAIR principles1. Boutiques descriptors are JSON objects containing a specification of the tool input data, parameters, and output data. They link to a Docker or Singularity container image where the tool and all its dependencies are installed and configured for execution. Boutiques tools can be reused in various platforms, such as workflow engines, as exemplified in TIGR-PURR (https://github.com/TIGRLab/TIGR_PURR), or in web platforms such as CBRAIN23 or VIP (https://www.creatis.insa-lyon.fr/vip/).

Boutiques tools can be published, archived, and retrieved in the Zenodo research archive or in the OpenAIRE-Nexus project. Once published, Boutiques tools receive a DOI, which makes their archives permanently findable.

Similar to the data integration layer, tools can be executed through both command-line and web interfaces. The Boutiques command-line tool can be used to run the tools locally with a uniform interface, provided that a container engine is installed. This is useful for testing analyses or processing smaller datasets. CONP datasets can be downloaded locally for processing through the DataLad command-line or Python API. Boutiques Python API also enables tool integration in external pipeline engines such as Pydra24, Nextflow25, or Apache Spark26.

For use-cases that benefit from the use of HPC clusters, the Clowdr command-line tool and Python API27 can easily be used to apply Boutiques tools concurrently to multiple subjects on HPC clusters available through the SLURM workload manager, such as the ones provided by Compute Canada (https://www.computecanada.ca/), or on the Amazon Elastic Computing Cloud (EC2). This allows CONP users to leverage their own resource allocation and to process CONP datasets through the DataLad interface.

Many CONP tools are also installed in CBRAIN23, a web portal interfaced with storage and computing resources at HPC centers, to provide a higher-level interface for users who do not want to use the command-line, or for developers who prefer to interact with HPC resources through a web API. CBRAIN can import Boutiques descriptors, and create web forms and HPC jobs to launch and monitor the tools. Pipelines that were installed as Docker images are converted to Singularity for deployment on HPC clusters. To facilitate the processing of datasets accessible via the CONP, CBRAIN also interfaces with DataLad, downloading files on-demand for processing.

Running a data analysis pipeline on CBRAIN requires a CBRAIN account. There is no current billing model associated with the compute part of the platform, because CBRAIN relies on academic computing resources, primarily Compute Canada, obtained through resource allocation competitions. The CBRAIN infrastructure allows for external compute resources to be attached to the platform such that an international research laboratory could use its own resources. CBRAIN also has a certain amount of computing time allocated on Compute Canada and when possible the team can offer these for reasonable usage. This needs to be directly requested to the CBRAIN infrastructure governance team through an email to CBRAIN support. Data derived from processing will be stored on the CBRAIN infrastructure, and the agreement by the CBRAIN team to process data will depend on both the compute time (if on CBRAIN Compute Canada allocation) and on the capacity to store these derived data. We note that CBRAIN can also attach data providers with the Principal Investigators own disk space allocation on Compute Canada, on other accessible infrastructures, or even on their own laboratory servers. Given the variety of situations, requests for compute time and disk space are handled on a case by case basis.

Finally, Boutiques executions, including local, Clowdr and CBRAIN ones, also collect anonymized provenance records for activity monitoring, traceability, and other applications.

Read this article:
Data and Tools Integration in the Canadian Open Neuroscience ... - Nature.com

The Neuroscience of Learning – New Trader U

The neuroscience study opens new avenues for understanding the brains role in learning and education. As researchers uncover more about the mechanisms underlying acquiring knowledge, educators can implement evidence-based strategies to enhance student outcomes. This blog post delves into the fascinating world of neuroscience, explores how the brain learns, and examines various learning theories and strategies informed by neuroscientific research.

Neuroscience refers to studying the nervous system, focusing on its role in behavior, cognition, and learning. The human brain, a complex organ, contains billions of neurons that transmit information through electrical and chemical signals. These neurons form networks, and the brains organization into different regions allows it to carry out specific functions.

Learning involves three primary processes: encoding, consolidation, and retrieval. The brain processes new information during encoding, while consolidation refers to stabilizing memories. Retrieval, on the other hand, involves recalling information from memory. Several brain regions, including the prefrontal cortex, hippocampus, and amygdala, contribute to these processes. The prefrontal cortex plays a role in decision-making, problem-solving, and critical thinking, while the hippocampus is essential for forming new memories. The amygdala is responsible for emotional processing and memory consolidation.

Neuronal plasticity, the brains ability to change and adapt due to experience, is critical to learning. Synaptic plasticity involves changes in the strength of connections between neurons, and neurogenesis refers to the formation of new neurons. Both of these processes contribute to the brains adaptability and capacity for learning.

Cognitive learning theories focus on the mental processes involved in learning. One such theory, the Information Processing Theory, likens the brain to a computer. According to this theory, information passes through three stages: sensory memory, short-term memory, and long-term memory. Another cognitive learning theory, Cognitive Load Theory, emphasizes working memory capacity limits. Effective learning requires managing cognitive load to prevent overloading.

Neuroscience research has identified several effective learning strategies, including retrieval practice, spaced repetition, and interleaving. Retrieval practice involves actively recalling information from memory, which has been shown to strengthen memory and improve long-term retention. Spaced repetition refers to revisiting material at increasingly longer intervals, a technique proven to enhance memory consolidation and retention. Interleaving involves mixing different topics or types of problems during study sessions, which can enhance cognitive flexibility and promote the better transfer of learning.

The amygdala plays a significant role in learning, processing emotional stimuli, and connecting them to memories. Emotional regulation, or the ability to manage emotions, can impact cognitive processes and learning outcomes. Chronic stress can impair memory and cognitive function, making it essential to develop strategies to reduce stress and promote a positive learning environment.

Learning disabilities are neurodevelopmental disorders that affect the brains ability to process information. Individuals with learning disabilities exhibit structural and functional differences in language, memory, and attention-related brain regions. Strategies for supporting individuals with learning disabilities include personalized learning plans, assistive technologies, and support from educators, therapists, and specialists.

The potential of neuroscientific research in education is immense. As researchers continue to expand our understanding of how learning occurs, educators can integrate these findings into evidence-based teaching strategies. Identifying individual learning preferences and needs can lead to more personalized educational experiences.

Technology also plays a role in the intersection of neuroscience and education. Neuroimaging techniques like functional magnetic resonance imaging (fMRI) and electroencephalography (EEG) allow researchers to study learning processes in real-time. Brain-computer interfaces and adaptive learning technologies hold promise for developing personalized learning experiences. Virtual reality and immersive learning environments can also provide unique educational opportunities that engage students on a deeper level.

Ethical considerations must be addressed in applying neuroscience to education. Balancing the benefits and potential risks of using neuroscientific data in educational settings is crucial. Issues of privacy, consent, and data security must be considered.

The field of neuroscience offers valuable insights into the brains role in learning and education. Educators can implement evidence-based strategies to enhance student outcomes by understanding the underlying learning mechanisms. Cognitive learning theories, such as Information Processing Theory and Cognitive Load Theory, can provide a framework for understanding the mental processes involved in learning.

Neuroscientific research has also informed effective learning strategies, such as retrieval practice, spaced repetition, and interleaving. These strategies have improved memory consolidation, retention, and cognitive flexibility. Additionally, understanding the impact of emotion on learning and the neuroscience of learning disabilities can help educators develop targeted support strategies for students with diverse needs.

As the field of neuroscience continues to grow, so too will its potential applications in education. Technology, including neuroimaging techniques and virtual reality, will undoubtedly play an increasingly important role in understanding and enhancing learning experiences. However, it is essential to address ethical considerations to ensure that these advancements benefit all students and protect their privacy and rights.

Read the original:
The Neuroscience of Learning - New Trader U